A Case of Pneumocystis Pneumonia after Cetuximab-based Bioradiotherapy

Asano Shinohara, Ryunosuke Kogo, Hideoki Uryu, Ryuji Yasumatsu, Torahiko Nakashima, Shizuo Komune

Research output: Contribution to journalArticle

Abstract

Reports of drug-induced interstitial pneumonia caused by Cetuximab have been increasing. Pneumocystis pneumonia is important as a differential diagnosis of drug-induced interstitial pneumonia. We report herein on a 64-year-old man with pneumocystis pneumonia after cetuximab-based bioradiotherapy for laryngeal cancer. After radiotherapy, the patient developed multi-drug resistant pneumonia. Chest CT imaging revealed diffuse ground-glass opacities in the lung field. He was diagnosed as having pneumocystis pneumonia based on the bronchoalveolar lavage (BAL) findings, and then his symptoms improved after treatment with Trimethoprim/Sulfamethoxazole. It is important to assess the risk factor for pneumocystis pneumonia for early its detection and treatment.

Original languageEnglish
Pages (from-to)204-209
Number of pages6
JournalNihon Jibiinkoka Gakkai kaiho
Volume119
Issue number3
Publication statusPublished - Mar 1 2016

Fingerprint

Pneumocystis Pneumonia
Interstitial Lung Diseases
Pharmaceutical Preparations
Laryngeal Neoplasms
Sulfamethoxazole Drug Combination Trimethoprim
Bronchoalveolar Lavage
Glass
Pneumonia
Differential Diagnosis
Radiotherapy
Thorax
Lung
Cetuximab
Therapeutics

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Shinohara, A., Kogo, R., Uryu, H., Yasumatsu, R., Nakashima, T., & Komune, S. (2016). A Case of Pneumocystis Pneumonia after Cetuximab-based Bioradiotherapy. Nihon Jibiinkoka Gakkai kaiho, 119(3), 204-209.

A Case of Pneumocystis Pneumonia after Cetuximab-based Bioradiotherapy. / Shinohara, Asano; Kogo, Ryunosuke; Uryu, Hideoki; Yasumatsu, Ryuji; Nakashima, Torahiko; Komune, Shizuo.

In: Nihon Jibiinkoka Gakkai kaiho, Vol. 119, No. 3, 01.03.2016, p. 204-209.

Research output: Contribution to journalArticle

Shinohara, A, Kogo, R, Uryu, H, Yasumatsu, R, Nakashima, T & Komune, S 2016, 'A Case of Pneumocystis Pneumonia after Cetuximab-based Bioradiotherapy', Nihon Jibiinkoka Gakkai kaiho, vol. 119, no. 3, pp. 204-209.
Shinohara A, Kogo R, Uryu H, Yasumatsu R, Nakashima T, Komune S. A Case of Pneumocystis Pneumonia after Cetuximab-based Bioradiotherapy. Nihon Jibiinkoka Gakkai kaiho. 2016 Mar 1;119(3):204-209.
Shinohara, Asano ; Kogo, Ryunosuke ; Uryu, Hideoki ; Yasumatsu, Ryuji ; Nakashima, Torahiko ; Komune, Shizuo. / A Case of Pneumocystis Pneumonia after Cetuximab-based Bioradiotherapy. In: Nihon Jibiinkoka Gakkai kaiho. 2016 ; Vol. 119, No. 3. pp. 204-209.
@article{e79592aba69e441cac3a2d0d146375b1,
title = "A Case of Pneumocystis Pneumonia after Cetuximab-based Bioradiotherapy",
abstract = "Reports of drug-induced interstitial pneumonia caused by Cetuximab have been increasing. Pneumocystis pneumonia is important as a differential diagnosis of drug-induced interstitial pneumonia. We report herein on a 64-year-old man with pneumocystis pneumonia after cetuximab-based bioradiotherapy for laryngeal cancer. After radiotherapy, the patient developed multi-drug resistant pneumonia. Chest CT imaging revealed diffuse ground-glass opacities in the lung field. He was diagnosed as having pneumocystis pneumonia based on the bronchoalveolar lavage (BAL) findings, and then his symptoms improved after treatment with Trimethoprim/Sulfamethoxazole. It is important to assess the risk factor for pneumocystis pneumonia for early its detection and treatment.",
author = "Asano Shinohara and Ryunosuke Kogo and Hideoki Uryu and Ryuji Yasumatsu and Torahiko Nakashima and Shizuo Komune",
year = "2016",
month = "3",
day = "1",
language = "English",
volume = "119",
pages = "204--209",
journal = "Journal of Otolaryngology of Japan",
issn = "0030-6622",
publisher = "Oto-Rhino-Laryngological Society of Japan Inc.",
number = "3",

}

TY - JOUR

T1 - A Case of Pneumocystis Pneumonia after Cetuximab-based Bioradiotherapy

AU - Shinohara, Asano

AU - Kogo, Ryunosuke

AU - Uryu, Hideoki

AU - Yasumatsu, Ryuji

AU - Nakashima, Torahiko

AU - Komune, Shizuo

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Reports of drug-induced interstitial pneumonia caused by Cetuximab have been increasing. Pneumocystis pneumonia is important as a differential diagnosis of drug-induced interstitial pneumonia. We report herein on a 64-year-old man with pneumocystis pneumonia after cetuximab-based bioradiotherapy for laryngeal cancer. After radiotherapy, the patient developed multi-drug resistant pneumonia. Chest CT imaging revealed diffuse ground-glass opacities in the lung field. He was diagnosed as having pneumocystis pneumonia based on the bronchoalveolar lavage (BAL) findings, and then his symptoms improved after treatment with Trimethoprim/Sulfamethoxazole. It is important to assess the risk factor for pneumocystis pneumonia for early its detection and treatment.

AB - Reports of drug-induced interstitial pneumonia caused by Cetuximab have been increasing. Pneumocystis pneumonia is important as a differential diagnosis of drug-induced interstitial pneumonia. We report herein on a 64-year-old man with pneumocystis pneumonia after cetuximab-based bioradiotherapy for laryngeal cancer. After radiotherapy, the patient developed multi-drug resistant pneumonia. Chest CT imaging revealed diffuse ground-glass opacities in the lung field. He was diagnosed as having pneumocystis pneumonia based on the bronchoalveolar lavage (BAL) findings, and then his symptoms improved after treatment with Trimethoprim/Sulfamethoxazole. It is important to assess the risk factor for pneumocystis pneumonia for early its detection and treatment.

UR - http://www.scopus.com/inward/record.url?scp=84984825572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984825572&partnerID=8YFLogxK

M3 - Article

VL - 119

SP - 204

EP - 209

JO - Journal of Otolaryngology of Japan

JF - Journal of Otolaryngology of Japan

SN - 0030-6622

IS - 3

ER -